Structure Therapeutics Inc.
GPCR
$19.61
$0.241.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 17.09% | -0.96% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 25.11% | 19.66% | |||
| Operating Income | -25.11% | -19.66% | |||
| Income Before Tax | -31.64% | -28.59% | |||
| Income Tax Expenses | 41.84% | -27.94% | |||
| Earnings from Continuing Operations | -31.66% | -28.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -31.66% | -28.38% | |||
| EBIT | -25.11% | -19.66% | |||
| EBITDA | -25.20% | -19.75% | |||
| EPS Basic | -31.21% | -28.28% | |||
| Normalized Basic EPS | -31.18% | -95.36% | |||
| EPS Diluted | -31.21% | -28.28% | |||
| Normalized Diluted EPS | -31.18% | -95.36% | |||
| Average Basic Shares Outstanding | 0.35% | 0.08% | |||
| Average Diluted Shares Outstanding | 0.35% | 0.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||